Clinical Trials Browser

OTHER × anetumab ravtansine × Clear all

NCT03455556 2023-01-06

Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer

Phase 1 Terminated

1 enrolled 1 chart

Carcinoma, Non-Small-Cell Lung

NCT03023722 2021-10-28

Phase II Anetumab Ravtansine in Pre-treated Mesothelin-expressing Pancreatic Cancer

Phase 2 Completed

18 enrolled 10 charts

Gastrointestinal

Pancreatic Neoplasms